DBVT Q1 2021 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-37.7% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$30M-1007.6% margin

Net Income

-$29M-1001.3% margin

EPS (Diluted)

$-2.70

QoQ Revenue Growth

+342.7%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$221M

Total Liabilities

$52M

Stockholders' Equity

$169M

Cash & Equivalents

$152M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$5M	-37.7%
Gross Profit	$3M	$5M	-37.7%
Operating Income	-$30M	-$41M	+28.1%
Net Income	-$29M	-$41M	+28.0%